CHC LABS INC.
|
ALUMINUM (82108) |
|
|
268.2 |
Osteomalacia, unspecified |
|
275.49 |
Other disorders of calcium metabolism |
|
280.9 |
Iron deficiency anemia, unspecified |
|
284.8 |
Other specified aplastic anemias |
|
284.9 |
Aplastic anemia, unspecified |
|
285.1 |
Acute posthemorrhagic anemia] |
|
294.8 |
Other specified organic brain syndromes (chronic) |
|
348.3 |
Encephalopathy, unspecified |
|
359.4* |
Toxic myopathy |
|
428.1 |
Left heart failure |
|
429.3 |
Cardiomegaly |
|
585 |
Chronic renal failure |
|
733.10-733.19 |
Pathologic fracture |
|
965.1 |
Poisoning by salicylates |
|
972.2 |
Poisoning by antilipemic and antiarteriosclerotic drugs |
|
973.0 |
Poisoning by antacids and antigastric secretion drugs |
|
976.1 |
Poisoning by antipruritics |
|
976.2 |
Poisoning by local astringents and local detergents |
|
976.3 |
Poisoning by emollients, demulcents, and protectants |
|
985.9 |
Toxic effect of unspecified metal |
|
E858.3* |
Accidental poisoning by agents primarily affecting cardiovascular system |
|
E858.4* |
Accidental poisoning by agents primarily affecting gastrointestinal system |
|
E858.7* |
Accidental poisoning by agents primarily affecting skin and mucous membrane, ophthalmological, otohinolaryngological, and dental drugs |
|
E935.3* |
Salicylates causing adverse effects in therapeutic use |
|
E942.2* |
Antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use |
|
E943.0* |
Antacids and antigastric secretion drugs causing adverse effects in therapeutic use |
|
E946.2* |
Local astringents and local detergents causing adverse effects in therapeutic use |
|
E946.3* |
Emollients, demulcents, and protectants causing adverse effects in therapeutic use |
|
E950.0* |
Suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics |
|
E950.4* |
Suicide and self-inflicted poisoning by other specified drugs and medicinal substances |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|